维普期刊资源整合服务平台（V6.5）

22篇 您的检索式：作者名="Kilburn LS"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Neocent:A randomised feasi- bility and translational study comparing neoadjuvant endocrine therapy with chemotherapy in er-rich postmenopausal primary breast cancer 显示文摘	Palmieri C Cleator S Kilburn LS	2014	Breast Cancer Res Treat2014，148，3：	1
2	'Triple negative' breast cancer:a new area for phase Ⅲ breast cancer clinical trials显示文摘	Kilburn LS	2008	Clin Oncol2008，20，1：	1
3	Triple negative breast eancer:a new area for phase III breast cancer clinical trials显示文摘	Kilburn LS	2008	Clin Oncol(R Coll Radiol)2008，20，1：	1
4	Suryival and safety of exemestane versus tamoxifen after 2 - 3 years' tamoxifen treatment ( intergroup exemestane study) : A randomised controlled trial显示文摘	Codmbes RC Kilburn LS Snowdon CF	2007	Lancet2007，369，4：	1
5	Survival and safety of ex- emestane versus tamoxifen after 2 - 3 years'tamoxifen treatment( Inter- group Exemestane Study) :a randomised controlled trial 显示文摘	Coombes RC Kilburn LS Snowdon CF	2007	Lancet2007，369，9561：	1
6	Survival and safety of exemestane versus tamoxifen after 2-3 yearsp tamox- ifen treatment (Intergroup Exemestane Study) : a randomised controlled trial显示文摘	Coombes RC Kilburn LS Snowdon CF	2007	Lancet2007，369，9561：	1
7	Survival and safety of exemestane versus tamoxifen after 2-3 years' tamoxifen treatment (Intergroup Exemestane Study):a randomized controlled trial显示文摘	Coombes RC Kilburn LS Snowdon CF		0，，9561：	1
8	Long-term assessment of quality oflife in the Intergroup Exemestane Study: 5 years post-randomisation显示文摘	Fallowfield LJ Kilburn LS Langridge C	2012	Br J Cancer2012，106，6：	1
9	'Triple negative' breast cancer: a new area for phase Ⅲ breast cancer clinical trials 显示文摘	Kilburn LS	2008	Clin Oncol2008，20，1：	1
10	Disease-related outcomes with long-term follow-up: an updated analysis of the intergroup excmestane study显示文摘	Bliss JM Kilburn LS Coleman RE	2012	J Clin Oncol2012，30，7：	1
11	Survival and safety of exemestane versus tamoxifen after 2-3 years' tamoxifen treatment (Intergroup Exemestane Study): a randomised controlled trial显示文摘	Coombes RC Kilburn LS Snowdon CF	2007	Lancet2007，369，9561：	1
12	Survival and safety of exemestane versus tamoxifen after 2-3 years' tamoxifen treatment (Intergroup Exemestane Study): a randomised controlled trial显示文摘	Coombes RC Kilburn LS Snowdon CF	2007	Lancet2007，369，9561：	1
13	Disease-related outcomes with long-term follow-up: an updated analysis of the intergroup exemestane study显示文摘	Bliss JM Kilburn LS Coleman RE	2012	J Clin Oncol2012，30，7：	1
14	Surviw al and safety of exemestane versus tamoxifen after 2-3 years' tamoxlfen treatment(Intergroup Exemestane Study) :a random- ised controlled trial显示文摘	Coombes RC Kilburn LS Snowdon CF	2007	Lancet2007，369，9561：	1
15	Survival and safety of exemestane versus tamoxifen after 2-3 years' tamoxifen treatment (Intergroup Exemestane Study ): a randomised controlled trial 显示文摘	Coombes RC Kilburn LS Snowdon CF	2007	Lancet2007，369，9561：	1
16	Survival and safety of exemestane versus tamoxifen after 2 - 3 years tamoxifen treatment ( Intergroup Exemestane Study ) : a randomized controlled trial显示文摘	Coombes RC Kilburn LS Snowdon CF	2007	Lancet2007，369，9561：	1
17	Survival and safety of exemestane versus tamoxifen after 2-3 years' tamoxifen treatment (Intergroup Exemestane Study): a randomised controlled trial显示文摘	Coombes RC Kilburn LS Snowdon CF	2007	Lancet2007，369，9561：	1
18	Fulvestrant plus anastrozole or placebo versus exemestane alone after progression on non-steroidal aromatase inhibitors in postmenopausal patients with hormone- receptor-positive locally advanced or metastatic breast cancer (SoFEA): a composite, multicentre, phase 3 randomised trial显示文摘	Johnston SR Kilburn LS Ellis P	2013	Lancet Oncol2013，14，10：	1
19	Survival and safety of exemestane versus tamoxifen after 2-3 year's tanmoxifen treatment(I- ntergroup Exemestane Study):a randomised controlled trial显示文摘	Coombes RC Kilburn LS Snowdon CF ct al	2007	Lane- et2007，369，：	1
20	Survival and safety of exemestane versus tamoxifen after 2 - 3 years ' tamoxifen treatment ( Intergroup Exemestane Study ) : a randomised controlled trial 显示文摘	Coombes RC Kilburn LS Snowdon CF	2007	Lancet2007，369，9561：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示